IDPs and Protein Degradation in the Cell

Instrumental Analysis of Intrinsically Disordered Proteins: Assessing Structure and Conformation

Volumn , Issue , 2010, Pages 1-36

  Shaul, Yosef ^a   Tsvetkov, Peter ^a   Reuven, Nina ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Assessing IDPs in living cell IDPs and protein degradation in cell; NQO1 regulating IDPS degradation by default; Protein degradation, role in every basic cellular process

Indexed keywords

EID: 84885504735     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470602614.ch1     Document Type: Chapter

References (150)

1. Alvarez - Castelao, B., and J. G. Castano. 2005. Mechanism of direct degradation of IkappaBalpha by 20S proteasome. FEBS Lett 579: 4797-802.
2. Amici, M., D. Sagratini, A. Pettinari, S. Pucciarelli, M. Angeletti, and A. M. Eleuteri. 2004. 20S proteasome mediated degradation of DHFR: implications in neurodegenerative disorders. Arch Biochem Biophys 422: 168-74.
3. Apcher, G. S., S. Heink, D. Zantopf, P. M. Kloetzel, H. P. Schmid, R. J. Mayer, and E. Kruger. 2003. Human immunodeficiency virus - 1 Tat protein interacts with distinct proteasomal alpha and beta subunits. FEBS Lett 553: 200-4.
4. Asher, G., Z. Bercovich, P. Tsvetkov, Y. Shaul, and C. Kahana. 2005. 20S proteasomal degradation of ornithine decarboxylase is regulated by NQO1. Mol Cell 17: 645-55.
5. Asher, G., J. Lotem, B. Cohen, L. Sachs, and Y. Shaul. 2001. Regulation of p53 stability and p53 - dependent apoptosis by NADH quinone oxidoreductase 1. Proc Natl Acad Sci U S A 98: 1188-93.
6. Asher, G., J. Lotem, R. Kama, L. Sachs, and Y. Shaul. 2002. NQO1 stabilizes p53 through a distinct pathway. Proc Natl Acad Sci U S A 99: 3099-104.
7. Asher, G., J. Lotem, L. Sachs, C. Kahana, and Y. Shaul. 2002. Mdm - 2 and ubiquitin - independent p53 proteasomal degradation regulated by NQO1. Proc Natl Acad Sci U S A 99: 13125-30.
8. Asher, G., J. Lotem, L. Sachs, and Y. Shaul. 2004. p53 - dependent apoptosis and NAD(P)H:quinone oxidoreductase 1. Methods Enzymol 382: 278-93.
9. Asher, G., J. Lotem, P. Tsvetkov, V. Reiss, L. Sachs, and Y. Shaul. 2003. P53 hot - spot mutants are resistant to ubiquitin - independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1. Proc Natl Acad Sci U S A 100: 15065-70.
10. Asher, G., N. Reuven, and Y. Shaul. 2006. 20S proteasomes and protein degradation " by default ". Bioessays 28: 844-9.
11. Asher, G., P. Tsvetkov, C. Kahana, and Y. Shaul. 2005. A mechanism of ubiquitin - independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev 19: 316-21.
12. Bajorek, M., D. Finley, and M. H. Glickman. 2003. Proteasome disassembly and downregulation is correlated with viability during stationary phase. Curr Biol 13: 1140-4.
13. Basbous, J., D. Chalbos, R. Hipskind, I. Jariel - Encontre, and M. Piechaczyk. 2007. Ubiquitin - independent proteasomal degradation of Fra - 1 is antagonized by Erk1/2 pathway - mediated phosphorylation of a unique C - terminal destabilizer. Mol Cell Biol 27: 3936-50.
14. Baugh, J. M., and E. V. Pilipenko. 2004. 20S proteasome differentially alters translation of different mRNAs via the cleavage of eIF4F and eIF3. Mol Cell 16: 575-86.
15. Bell, S., C. Klein, L. Muller, S. Hansen, and J. Buchner. 2002. p53 contains large unstructured regions in its native state. J Mol Biol 322: 917-27.
16. Benaroudj, N., E. Tarcsa, P. Cascio, and A. L. Goldberg. 2001. The unfolding of substrates and ubiquitin - independent protein degradation by proteasomes. Biochimie 83: 311-8.
17. Bercovich, Z., and C. Kahana. 1993. Involvement of the 20S proteasome in the degradation of ornithine decarboxylase. Eur J Biochem 213: 205-10.
18. Bercovich, Z., Y. Rosenberg - Hasson, A. Ciechanover, and C. Kahana. 1989. Degradation of ornithine decarboxylase in reticulocyte lysate is ATP - dependent but ubiquitin - independent. J Biol Chem 264: 15949-52.
19. Berezutskaya, E., and S. Bagchi. 1997. The human papillomavirus E7 oncoprotein functionally interacts with the S4 subunit of the 26 S proteasome. J Biol Chem 272: 30135-40.
20. Bloom, J., V. Amador, F. Bartolini, G. DeMartino, and M. Pagano. 2003. Proteasome - mediated degradation of p21 via N - terminal ubiquitinylation. Cell 115: 71-82.
21. Bloom, J., and M. Pagano. 2004. To be or not to be ubiquitinated? Cell Cycle 3: 138-40.
22. Bossis, G., P. Ferrara, C. Acquaviva, I. Jariel - Encontre, and M. Piechaczyk. 2003. c - Fos proto - oncoprotein is degraded by the proteasome independently of its own ubiquitinylation in vivo. Mol Cell Biol 23: 7425-36.
23. Bothner, B., W. S. Lewis, E. L. DiGiammarino, J. D. Weber, S. J. Bothner, and R. W. Kriwacki. 2001. Defining the molecular basis of Arf and Hdm2 interactions. J Mol Biol 314: 263-77.
24. Bruschweiler, R., X. Liao, and P. E. Wright. 1995. Long - range motional restrictions in a multidomain zinc - finger protein from anisotropic tumbling. Science 268: 886-9.
25. Buchler, N. E., U. Gerland, and T. Hwa. 2005. Nonlinear protein degradation and the function of genetic circuits. Proc Natl Acad Sci U S A 102: 9559-64.
26. Campbell, K. M., A. R. Terrell, P. J. Laybourn, and K. J. Lumb. 2000. Intrinsic structural disorder of the C - terminal activation domain from the bZIP transcription factor Fos. Biochemistry 39: 2708-13.
27. Camus, S., S. Menendez, C. F. Cheok, L. F. Stevenson, S. Lain, and D. P. Lane. 2007. Ubiquitin - independent degradation of p53 mediated by high - risk human papillomavirus protein E6. Oncogene 26: 4059-70.
28. Cardozo, C., and C. Michaud. 2002. Proteasome - mediated degradation of tau proteins occurs independently of the chymotrypsin - like activity by a nonprocessive pathway. Arch Biochem Biophys 408: 103-10.
29. Carreras, C. W., and D. V. Santi. 1995. The catalytic mechanism and structure of thymidylate synthase. Annu Rev Biochem 64: 721-62.
30. Chen, X., L. F. Barton, Y. Chi, B. E. Clurman, and J. M. Roberts. 2007. Ubiquitin - independent degradation of cell - cycle inhibitors by the REGgamma proteasome. Mol Cell 26: 843-52.
31. Chinenov, Y., and T. K. Kerppola. 2001. Close encounters of many kinds: Fos - Jun interactions that mediate transcription regulatory specificity. Oncogene 20: 2438-52.
32. Chiu, Y. H., Q. Sun, and Z. J. Chen. 2007. E1 - L2 activates both ubiquitin and FAT10. Mol Cell 27: 1014-23.
33. Chowdary, D. R., J. J. Dermody, K. K. Jha, and H. L. Ozer. 1994. Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway. Mol Cell Biol 14: 1997-2003.
34. Ciechanover, A., and R. Ben - Saadon. 2004. N - terminal ubiquitination: more protein substrates join in. Trends Cell Biol 14: 103-6.
35. Ciechanover, A., and P. Brundin. 2003. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40: 427-46.
36. Coffino, P. 2001. Antizyme, a mediator of ubiquitin - independent proteasomal degradation. Biochimie 83: 319-23.
37. Coffino, P. 2001. Regulation of cellular polyamines by antizyme. Nat Rev Mol Cell Biol 2: 188-94.
38. Coleman, M. L., C. J. Marshall, and M. F. Olson. 2003. Ras promotes p21(Waf1/ Cip1) protein stability via a cyclin D1 - imposed block in proteasome - mediated degradation. EMBO J 22: 2036-46.
39. David, D. C., R. Layfield, L. Serpell, Y. Narain, M. Goedert, and M. G. Spillantini. 2002. Proteasomal degradation of tau protein. J Neurochem 83: 176-85.
40. Dornan, D., I. Wertz, H. Shimizu, D. Arnott, G. D. Frantz, P. Dowd, K. O'Rourke, H. Koeppen, and V. M. Dixit. 2004. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 429: 86-92.
41. Dosztanyi, Z., J. Chen, A. K. Dunker, I. Simon, and P. Tompa. 2006. Disorder and sequence repeats in hub proteins and their implications for network evolution. J Proteome Res 5: 2985-95.
42. Dunker, A. K., C. J. Brown, J. D. Lawson, L. M. Iakoucheva, and Z. Obradovic. 2002. Intrinsic disorder and protein function. Biochemistry 41: 6573-82.
43. Dunker, A. K., Z. Obradovic, P. Romero, E. C. Garner, and C. J. Brown. 2000. Intrinsic protein disorder in complete genomes. Genome Inform Ser Workshop Genome Inform 11: 161-71.
44. Dyson, H. J., and P. E. Wright. 2005. Intrinsically unstructured proteins and their functions. Nat Rev Mol Cell Biol 6: 197-208.
45. Elliott, E., P. Tsvetkov, and I. Ginzburg. 2007. BAG - 1 associates with Hsc70.Tau complex and regulates the proteasomal degradation of Tau protein. J Biol Chem 282: 37276-84.
46. Errami, A., V. Smider, W. K. Rathmell, D. M. He, E. A. Hendrickson, M. Z. Zdzienicka, and G. Chu. 1996. Ku86 defines the genetic defect and restores X - ray resistance and V(D)J recombination to complementation group 5 hamster cell mutants. Mol Cell Biol 16: 1519-26.
47. Ferrara, P., E. Andermarcher, G. Bossis, C. Acquaviva, F. Brockly, I. Jariel - Encontre, and M. Piechaczyk. 2003. The structural determinants responsible for c - Fos protein proteasomal degradation differ according to the conditions of expression. Oncogene 22: 1461-74.
48. Ferrington, D. A., H. Sun, K. K. Murray, J. Costa, T. D. Williams, D. J. Bigelow, and T. C. Squier. 2001. Selective degradation of oxidized calmodulin by the 20 S proteasome. J Biol Chem 276: 937-43.
49. Fink, A. L. 1999. Chaperone - mediated protein folding. Physiol Rev 79: 425-49.
50. Fjeld, C. C., W. T. Birdsong, and R. H. Goodman. 2003. Differential binding of NAD+ and NADH allows the transcriptional corepressor carboxyl - terminal binding protein to serve as a metabolic sensor. Proc Natl Acad Sci U S A 100: 9202-7.
51. Forsthoefel, A. M., M. M. Pena, Y. Y. Xing, Z. Rafique, and F. G. Berger. 2004. Structural determinants for the intracellular degradation of human thymidylate synthase. Biochemistry 43: 1972-9.
52. Friedler, A., D. B. Veprintsev, S. M. Freund, K. I. von Glos, and A. R. Fersht. 2005. Modulation of binding of DNA to the C - terminal domain of p53 by acetylation . Structure 13: 629-36.
53. Garate, M., R. P. Wong, E. I. Campos, Y. Wang, and G. Li. 2008. NAD(P)H quinone oxidoreductase 1 inhibits the proteasomal degradation of the tumour suppressor p33(ING1b). EMBO Rep 9: 576-81.
54. Glickman, M. H., and A. Ciechanover. 2002. The ubiquitin - proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82: 373-428.
55. Gong, X., L. Kole, K. Iskander, and A. K. Jaiswal. 2007. NRH:quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20s proteasomal degradation leading to stabilization and activation of p53. Cancer Res 67: 5380-8.
56. Groll, M., M. Bajorek, A. Kohler, L. Moroder, D. M. Rubin, R. Huber, M. H. Glickman, and D. Finley. 2000. A gated channel into the proteasome core particle. Nat Struct Biol 7: 1062-7.
57. Groll, M., L. Ditzel, J. Lowe, D. Stock, M. Bochtler, H. D. Bartunik, and R. Huber. 1997. Structure of 20S proteasome from yeast at 2.4 A resolution. Nature 386: 463-71.
58. Gu, Y., S. Jin, Y. Gao, D. T. Weaver, and F. W. Alt. 1997. Ku70 - deficient embryonic stem cells have increased ionizing radiosensitivity, defective DNA end - binding activity, and inability to support V(D)J recombination. Proc Natl Acad Sci U S A 94: 8076-81.
59. Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387: 296-9.
60. Hershko, A. 1996. Lessons from the discovery of the ubiquitin system. Trends Biochem Sci 21: 445-9.
61. Hershko, A., and A. Ciechanover. 1998. The ubiquitin system. Annu Rev Biochem 67: 425-79.
62. Hess, J., P. Angel, and M. Schorpp - Kistner. 2004. AP - 1 subunits: quarrel and harmony among siblings. J Cell Sci 117: 5965-73.
63. Hochstrasser, M. 1996. Ubiquitin - dependent protein degradation. Annu Rev Genet 30: 405-39.
64. Hwang, S. G., S. S. Yu, J. H. Ryu, H. B. Jeon, Y. J. Yoo, S. H. Eom, and J. S. Chun. 2005. Regulation of beta - catenin signaling and maintenance of chondrocyte differentiation by ubiquitin - independent proteasomal degradation of alpha - catenin. J Biol Chem 280: 12758-65.
65. Jariel - Encontre, I., G. Bossis, and M. Piechaczyk. 2008. Ubiquitin - independent degradation of proteins by the proteasome. Biochim Biophys Acta 1786: 153-177.
66. Jariel - Encontre, I., M. Pariat, F. Martin, S. Carillo, C. Salvat, and M. Piechaczyk. 1995. Ubiquitinylation is not an absolute requirement for degradation of c - Jun protein by the 26 S proteasome. J Biol Chem 270: 11623-7.
67. Jin, J., X. Li, S. P. Gygi, and J. W. Harper. 2007. Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging. Nature 447: 1135-8.
68. Johnston, J. A., E. S. Johnson, P. R. Waller, and A. Varshavsky. 1995. Methotrexate inhibits proteolysis of dihydrofolate reductase by the N - end rule pathway. J Biol Chem 270: 8172-8.
69. Ju, D., and Y. Xie. 2004. Proteasomal degradation of RPN4 via two distinct mechanisms, ubiquitin - dependent and - independent. J Biol Chem 279: 23851-4.
70. Kalejta, R. F., and T. Shenk. 2003. Proteasome - dependent, ubiquitin - independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein. Proc Natl Acad Sci U S A 100: 3263-8.
71. Keck, S., R. Nitsch, T. Grune, and O. Ullrich. 2003. Proteasome inhibition by paired helical filament - tau in brains of patients with Alzheimer ' s disease. J Neurochem 85: 115-22.
72. Keller, J. N., K. B. Hanni, and W. R. Markesbery. 2000. Impaired proteasome function in Alzheimer ' s disease. J Neurochem 75: 436-9.
73. Kisselev, A. F., T. N. Akopian, K. M. Woo, and A. L. Goldberg. 1999. The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation . J Biol Chem 274: 3363-71.
74. Kong, X., B. Alvarez - Castelao, Z. Lin, J. G. Castano, and J. Caro. 2007. Constitutive/hypoxic degradation of HIF - alpha proteins by the proteasome is independent of von Hippel Lindau protein ubiquitylation and the transactivation activity of the protein. J Biol Chem 282: 15498-505.
75. Kozlov, G., J. F. Trempe, K. Khaleghpour, A. Kahvejian, I. Ekiel, and K. Gehring. 2001. Structure and function of the C - terminal PABC domain of human poly(A) - binding protein. Proc Natl Acad Sci U S A 98: 4409-13.
76. Krappmann, D., F. G. Wulczyn, and C. Scheidereit. 1996. Different mechanisms control signal - induced degradation and basal turnover of the NF - kappaB inhibitor IkappaB alpha in vivo. EMBO J 15: 6716-26.
77. Kristiansen, M., P. Deriziotis, D. E. Dimcheff, G. S. Jackson, H. Ovaa, H. Naumann, A. R. Clarke, F. W. van Leeuwen, V. Menendez - Benito, N. P. Dantuma, J. L. Portis, J. Collinge, and S. J. Tabrizi. 2007. Disease- associated prion protein oligomers inhibit the 26S proteasome. Mol Cell 26: 175-88.
78. Kroll, M., M. Conconi, M. J. Desterro, A. Marin, D. Thomas, B. Friguet, R. T. Hay, J. L. Virelizier, F. Arenzana - Seisdedos, and M. S. Rodriguez. 1997. The carboxy - terminus of I kappaB alpha determines susceptibility to degradation by the catalytic core of the proteasome. Oncogene 15: 1841-50.
79. Kubbutat, M. H., S. N. Jones, and K. H. Vousden. 1997. Regulation of p53 stability by Mdm2. Nature 387: 299-303.
80. Kuwajima, K. 1989. The molten globule state as a clue for understanding the folding and cooperativity of globular - protein structure. Proteins 6: 87-103.
81. Leng, R. P., Y. Lin, W. Ma, H. Wu, B. Lemmers, S. Chung, J. M. Parant, G. Lozano, R. Hakem, and S. Benchimol. 2003. Pirh2, a p53 - induced ubiquitin - protein ligase, promotes p53 degradation. Cell 112: 779-91.
82. Li, X., L. Amazit, W. Long, D. M. Lonard, J. J. Monaco, and B. W. O ' Malley. 2007. Ubiquitin - and ATP - independent proteolytic turnover of p21 by the REGgamma - proteasome pathway. Mol Cell 26: 831-42.
83. Li, X., D. M. Lonard, S. Y. Jung, A. Malovannaya, Q. Feng, J. Qin, S. Y. Tsai, M. J. Tsai, and B. W. O ' Malley. 2006. The SRC - 3/AIB1 coactivator is degraded in a ubiquitin - and ATP - independent manner by the REGgamma proteasome. Cell 124: 381-92.
84. Liu, C. W., M. J. Corboy, G. N. DeMartino, and P. J. Thomas. 2003. Endoproteolytic activity of the proteasome. Science 299: 408-11.
85. Mani - Telang, P., M. Sutrias - Grau, G. Williams, and D. N. Arnosti. 2007. Role of NAD binding and catalytic residues in the C - terminal binding protein corepressor . FEBS Lett 581: 5241-6.
86. Masson, P., O. Andersson, U. M. Petersen, and P. Young. 2001. Identification and characterization of a Drosophila nuclear proteasome regulator. A homolog of human 11 S REGgamma (PA28gamma). J Biol Chem 276: 1383-90.
87. Mathes, E., E. L. O ' Dea, A. Hoffmann, and G. Ghosh. 2008. NF - kappaB dictates the degradation pathway of IkappaBalpha. EMBO J 27: 1357-67.
88. McLauchlan, J. 2000. Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes. J Viral Hepat 7: 2-14.
89. McLure, K. G., M. Takagi, and M. B. Kastan. 2004. NAD+ modulates p53 DNA binding specificity and function. Mol Cell Biol 24: 9958-67.
90. Moore, D. J., A. B. West, V. L. Dawson, and T. M. Dawson. 2005. Molecular pathophysiology of Parkinson ' s disease. Annu Rev Neurosci 28: 57-87.
91. Moorthy, A. K., O. V. Savinova, J. Q. Ho, V. Y. Wang, D. Vu, and G. Ghosh. 2006. The 20S proteasome processes NF - kappaB1 p105 into p50 in a translation - independent manner. EMBO J 25: 1945-56.
92. Moriishi, K., T. Okabayashi, K. Nakai, K. Moriya, K. Koike, S. Murata, T. Chiba, K. Tanaka, R. Suzuki, T. Suzuki, T. Miyamura, and Y. Matsuura. 2003. Proteasome activator PA28gamma - dependent nuclear retention and degradation of hepatitis C virus core protein. J Virol 77: 10237-49.
93. Navon, A., and A. L. Goldberg. 2001. Proteins are unfolded on the surface of the ATPase ring before transport into the proteasome. Mol Cell 8: 1339-49.
94. O ' Dea, E. L., D. Barken, R. Q. Peralta, K. T. Tran, S. L. Werner, J. D. Kearns, A. Levchenko, and A. Hoffmann. 2007. A homeostatic model of IkappaB metabolism to control constitutive NF - kappaB activity. Mol Syst Biol 3: 111.
95. O'Dea, E. L., J. D. Kearns, and A. Hoffmann. 2008. UV as an amplifier rather than inducer of NF - kappaB activity. Mol Cell 30: 632-41.
96. Ogiso, Y., A. Tomida, H. D. Kim, and T. Tsuruo. 1999. Glucose starvation and hypoxia induce nuclear accumulation of proteasome in cancer cells. Biochem Biophys Res Commun 258: 448-52.
97. Pande, A. H., D. Moe, M. Jamnadas, S. A. Tatulian, and K. Teter. 2006. The pertussis toxin S1 subunit is a thermally unstable protein susceptible to degradation by the 20S proteasome. Biochemistry 45: 13734-40.
98. Pande, A. H., P. Scaglione, M. Taylor, K. N. Nemec, S. Tuthill, D. Moe, R. K. Holmes, S. A. Tatulian, and K. Teter. 2007. Conformational instability of the cholera toxin A1 polypeptide. J Mol Biol 374: 1114-28.
99. Park, Y., Y. P. Hwang, J. S. Lee, S. H. Seo, S. K. Yoon, and J. B. Yoon. 2005. Proteasomal ATPase - associated factor 1 negatively regulates proteasome activity by interacting with proteasomal ATPases. Mol Cell Biol 25: 3842-53.
100. Pelzer, C., I. Kassner, K. Matentzoglu, R. K. Singh, H. P. Wollscheid, M. Scheffner, G. Schmidtke, and M. Groettrup. 2007. UBE1L2, a novel E1 enzyme specific for ubiquitin. J Biol Chem 282: 23010-4.
101. Pena, M. M., Y. Y. Xing, S. Koli, and F. G. Berger. 2006. Role of N - terminal residues in the ubiquitin - independent degradation of human thymidylate synthase. Biochem J 394: 355-63.
102. Penela, P., A. Ruiz - Gomez, J. G. Castano, and F. Mayor, Jr. 1998. Degradation of the G protein - coupled receptor kinase 2 by the proteasome pathway. J Biol Chem 273: 35238-44.
103. Petropoulos, L., and J. Hiscott. 1998. Association between HTLV - 1 Tax and I kappa B alpha is dependent on the I kappa B alpha phosphorylation state. Virology 252: 189-99.
104. Pickart, C. M. 2001. Mechanisms underlying ubiquitination. Annu Rev Biochem 70: 503-33.
105. Pollice, A., M. Sepe, V. R. Villella, F. Tolino, M. Vivo, V. Calabro, and G. La Mantia. 2007. TBP - 1 protects the human oncosuppressor p14ARF from proteasomal degradation. Oncogene 26: 5154-62.
106. Poppek, D., S. Keck, G. Ermak, T. Jung, A. Stolzing, O. Ullrich, K. J. Davies, and T. Grune. 2006. Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress. Biochem J 400: 511-20.
107. Prakash, S., L. Tian, K. S. Ratliff, R. E. Lehotzky, and A. Matouschek. 2004. An unstructured initiation site is required for efficient proteasome - mediated degradation . Nat Struct Mol Biol 11: 830-7.
108. Prilusky, J., C. E. Felder, T. Zeev - Ben - Mordehai, E. H. Rydberg, O. Man, J. S. Beckmann, I. Silman, and J. L. Sussman. 2005. FoldIndex: a simple tool to predict whether a given protein sequence is intrinsically unfolded. Bioinformatics 21: 3435-8.
109. Rao, P. V., J. Horwitz, and J. S. Zigler, Jr. 1994. Chaperone - like activity of alpha - crystallin. The effect of NADPH on its interaction with zeta - crystallin. J Biol Chem 269: 13266-72.
110. Realini, C., C. C. Jensen, Z. Zhang, S. C. Johnston, J. R. Knowlton, C. P. Hill, and M. Rechsteiner. 1997. Characterization of recombinant REGalpha, REGbeta, and REGgamma proteasome activators. J Biol Chem 272: 25483-92.
111. Rechsteiner, M., and C. P. Hill. 2005. Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors. Trends Cell Biol 15: 27-33.
112. Reinheckel, T., N. Sitte, O. Ullrich, U. Kuckelkorn, K. J. Davies, and T. Grune. 1998. Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem J 335 ( Pt 3 ): 637-42.
113. Reinheckel, T., O. Ullrich, N. Sitte, and T. Grune. 2000. Differential impairment of 20S and 26S proteasome activities in human hematopoietic K562 cells during oxidative stress. Arch Biochem Biophys 377: 65-8.
114. Rosenberg - Hasson, Y., Z. Bercovich, A. Ciechanover, and C. Kahana. 1989. Degradation of ornithine decarboxylase in mammalian cells is ATP dependent but ubiquitin independent. Eur J Biochem 185: 469-74.
115. Sanchez - Puig, N., D. B. Veprintsev, and A. R. Fersht. 2005. Binding of natively unfolded HIF - 1alpha ODD domain to p53. Mol Cell 17: 11-21.
116. Sasaki, T., H. Kojima, R. Kishimoto, A. Ikeda, H. Kunimoto, and K. Nakajima. 2006. Spatiotemporal regulation of c - Fos by ERK5 and the E3 ubiquitin ligase UBR1, and its biological role. Mol Cell 24: 63-75.
117. Scheffner, M., J. M. Huibregtse, R. D. Vierstra, and P. M. Howley. 1993. The HPV - 16 E6 and E6 - AP complex functions as a ubiquitin - protein ligase in the ubiquitination of p53. Cell 75: 495-505.
118. Sdek, P., H. Ying, D. L. Chang, W. Qiu, H. Zheng, R. Touitou, M. J. Allday, and Z. X. Xiao. 2005. MDM2 promotes proteasome - dependent ubiquitin - independent degradation of retinoblastoma protein. Mol Cell 20: 699-708.
119. Sheaff, R. J., J. D. Singer, J. Swanger, M. Smitherman, J. M. Roberts, and B. E. Clurman. 2000. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol Cell 5: 403-10.
120. Sherr, C. J. 2001. The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol 2: 731-7.
121. Shojania, S., and J. D. O ' Neil. 2006. HIV - 1 Tat is a natively unfolded protein: the solution conformation and dynamics of reduced HIV - 1 Tat - (1 - 72) by NMR spectroscopy . J Biol Chem 281: 8347-56.
122. Sickmeier, M., J. A. Hamilton, T. LeGall, V. Vacic, M. S. Cortese, A. Tantos, B. Szabo, P. Tompa, J. Chen, V. N. Uversky, Z. Obradovic, and A. K. Dunker. 2007. DisProt: the Database of Disordered Proteins. Nucleic Acids Res 35: D786-93.
123. Smet, C., A. Leroy, A. Sillen, J. M. Wieruszeski, I. Landrieu, and G. Lippens. 2004. Accepting its random coil nature allows a partial NMR assignment of the neuronal Tau protein. Chembiochem 5: 1639-46.
124. Smith, D. M., S. C. Chang, S. Park, D. Finley, Y. Cheng, and A. L. Goldberg. 2007. Docking of the proteasomal ATPases ' carboxyl termini in the 20S proteasome ' s alpha ring opens the gate for substrate entry. Mol Cell 27: 731-44.
125. Sorokin, A. V., A. A. Selyutina, M. A. Skabkin, S. G. Guryanov, I. V. Nazimov, C. Richard, J. Th ' ng, J. Yau, P. H. Sorensen, L. P. Ovchinnikov, and V. Evdokimova. 2005. Proteasome - mediated cleavage of the Y - box - binding protein 1 is linked to DNA - damage stress response. EMBO J 24: 3602-12.
126. Takeuchi, J., H. Chen, and P. Coffino. 2007. Proteasome substrate degradation requires association plus extended peptide. EMBO J 26: 123-31.
127. Tang, K. S., A. R. Fersht, and L. S. Itzhaki. 2003. Sequential unfolding of ankyrin repeats in tumor suppressor p16. Structure 11: 67-73.
128. Tarcsa, E., G. Szymanska, S. Lecker, C. M. O ' Connor, and A. L. Goldberg. 2000. Ca2+ - free calmodulin and calmodulin damaged by in vitro aging are selectively degraded by 26 S proteasomes without ubiquitination. J Biol Chem 275: 20295-301.
129. Tenzer, S., L. Stoltze, B. Schonfisch, J. Dengjel, M. Muller, S. Stevanovic, H. G. Rammensee, and H. Schild. 2004. Quantitative analysis of prion - protein degradation by constitutive and immuno - 20S proteasomes indicates differences correlated with disease susceptibility. J Immunol 172: 1083-91.
130. Timchenko, N. A., T. E. Harris, M. Wilde, T. A. Bilyeu, B. L. Burgess - Beusse, M. J. Finegold, and G. J. Darlington. 1997. CCAAT/enhancer binding protein alpha regulates p21 protein and hepatocyte proliferation in newborn mice. Mol Cell Biol 17: 7353-61.
131. Tofaris, G. K., R. Layfield, and M. G. Spillantini. 2001. alpha - synuclein metabolism and aggregation is linked to ubiquitin - independent degradation by the proteasome. FEBS Lett 509: 22-6.
132. Tompa, P. 2005. The interplay between structure and function in intrinsically unstructured proteins. FEBS Lett 579: 3346-54.
133. Touitou, R., J. O ' Nions, J. Heaney, and M. J. Allday. 2005. Epstein - Barr virus EBNA3 proteins bind to the C8/alpha7 subunit of the 20S proteasome and are degraded by 20S proteasomes in vitro, but are very stable in latently infected B cells. J Gen Virol 86: 1269-77.
134. Touitou, R., J. Richardson, S. Bose, M. Nakanishi, J. Rivett, and M. J. Allday. 2001. A degradation signal located in the C - terminus of p21WAF1/CIP1 is a binding site for the C8 alpha - subunit of the 20S proteasome. EMBO J 20: 2367-75.
135. Tsvetkov, P., G. Asher, A. Paz, N. Reuven, J. L. Sussman, I. Silman, and Y. Shaul. 2007. Operational definition of intrinsically unstructured protein sequences based on susceptibility to the 20S proteasome. Proteins 70: 1357-1366.
136. Uversky, V. N., J. R. Gillespie, and A. L. Fink. 2000. Why are " natively unfolded " proteins unstructured under physiologic conditions? Proteins 41: 415-27.
137. Venkatraman, P., R. Wetzel, M. Tanaka, N. Nukina, and A. L. Goldberg. 2004. Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine - containing proteins. Mol Cell 14: 95-104.
138. Vogelstein, B., D. Lane, and A. J. Levine. 2000. Surfing the p53 network. Nature 408: 307-10.
139. Voges, D., P. Zwickl, and W. Baumeister. 1999. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem 68: 1015-68.
140. Wenzel, T., and W. Baumeister. 1995. Conformational constraints in protein degradation by the 20S proteasome. Nat Struct Biol 2: 199-204.
141. Yoshida, M., K. Yoshida, G. Kozlov, N. S. Lim, G. De Crescenzo, Z. Pang, J. J. Berlanga, A. Kahvejian, K. Gehring, S. S. Wing, and N. Sonenberg. 2006. Poly(A) binding protein (PABP) homeostasis is mediated by the stability of its inhibitor, Paip2. EMBO J 25: 1934-44.
142. Yu, H., G. Kaung, S. Kobayashi, and R. R. Kopito. 1997. Cytosolic degradation of T - cell receptor alpha chains by the proteasome. J Biol Chem 272: 20800-4.
143. Zhang, M., C. M. Pickart, and P. Coffino. 2003. Determinants of proteasome recognition of ornithine decarboxylase, a ubiquitin - independent substrate. EMBO J 22: 1488-96.
144. Zhang, Q., D. W. Piston, and R. H. Goodman. 2002. Regulation of corepressor function by nuclear NADH. Science 295: 1895-7.
145. Zhang, Y. J., Y. F. Xu, Y. H. Liu, J. Yin, H. L. Li, Q. Wang, and J. Z. Wang. 2006. Peroxynitrite induces Alzheimer - like tau modifications and accumulation in rat brain and its underlying mechanisms. FASEB J 20: 1431-42.
146. Zhang, Z., W. Hu, L. Cano, T. D. Lee, D. J. Chen, and Y. Chen. 2004. Solution structure of the C - terminal domain of Ku80 suggests important sites for protein - protein interactions. Structure 12: 495-502.
147. Zhang, Z., L. Zhu, D. Lin, F. Chen, D. J. Chen, and Y. Chen. 2001. The three - dimensional structure of the C - terminal DNA - binding domain of human Ku70. J Biol Chem 276: 38231-6.
148. Zheng, L., R. G. Roeder, and Y. Luo. 2003. S phase activation of the histone H2B promoter by OCA - S, a coactivator complex that contains GAPDH as a key component. Cell 114: 255-66.
149. Zhou, S., and J. W. Dewille. 2007. Proteasome - mediated CCAAT/enhancer - binding protein delta (C/EBPdelta) degradation is ubiquitin - independent. Biochem J 405: 341-9.
150. Zwickl, P., and W. Baumeister. 1999. AAA - ATPases at the crossroads of protein life and death. Nat Cell Biol 1: E97-8.